Apparent life-threatening event in infancy

Article information

Korean J Pediatr. 2016;59(9):347-354

Publication date (electronic) : 2016 September 21

doi : https://doi.org/10.3345/kjp.2016.59.9.347

Hee Joung Choi, MD, PhD ¹, Yeo Hyang Kim, MD, PhD ²

¹Department of Pediatrics, Keimyung University School of Medicine, Daegu, Korea.

²Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea.

Corresponding author: Yeo Hyang Kim, MD, PhD. Department of Pediatrics, Kyungpook National University School of Medicine, 680 Gukchaebosangro, Jung-gu, Daegu 41944, Korea. Tel: +82-53-200-5704, Fax: +82-53-425-6683, kimyhmd@knu.ac.kr

Received 2015 August 07; Revised 2015 September 29; Accepted 2015 October 07.

Abstract

An apparent life-threatening event (ALTE) is defined as the combination of clinical presentations such as apnea, marked change in skin and muscle tone, gagging, or choking. It is a frightening event, and it predominantly occurs during infancy at a mean age of 1–3 months. The causes of ALTE are categorized into problems that are: gastrointestinal (50%), neurological (30%), respiratory (20%), cardiovascular (5%), metabolic and endocrine (2%–5%), or others such as child abuse. Up to 50% of ALTEs are idiopathic, where the cause cannot be diagnosed. Infants with an ALTE are often asymptomatic at hospital and there is no standard workup protocol for ALTE. Therefore, a detailed initial history and physical examination are important to determine the extent of the medical evaluation and treatment. Regardless of the cause of an ALTE, all infants with an ALTE should require hospitalization and continuous cardiorespiratory monitoring and evaluation for at least 24 hours. The natural course of ALTEs has seemed benign, and the outcome is generally associated with the affected infants' underlying disease. In conclusion, systemic diagnostic evaluation and adequate treatment increases the survival and quality of life for most affected infants.

Keywords: Infantile apparent life-threatening event; Infant; Apnea

Introduction

It is not uncommon for clinicians to meet anxious parents in the Emergency Department (ED) who are frightened by the abrupt changes in the health of their baby. Since the 1970s, there were reports about episodes occurring in infants characterized by an acute and unexpected change in conduct, either with or without apnea. These episodes were mentioned to as "near-misses" for sudden infant death syndrome (SIDS)1), and were thus believed to be a possible cause of SIDS. However, in recent times, these episodes have been defined as apparent life-threatening events (ALTEs)2). ALTEs are an ongoing challenge for clinicians because these events have vague and heterogeneous clinical presentations.

Definition

SIDS is defined as the sudden death of an infant <1 year of age, where there is no explanation for death even after thorough investigations including: complete autopsy, examination of the death scene and review of the clinical history3). In contrast, the diagnosis of an ALTE is based on symptomatology rather than pathophysiology. In 1986, the National Institutes of Health consensus conference defined an ALTE as "an episode that is characterized by some combination of apnea (centrally or occasionally obstructive), color change (usually cyanotic or pallid, but occasionally erythematous or plethoric), marked change in muscle tone (usually marked limpness), choking, or gagging2).

Up to now, it has not been confirmed that ALTEs are really near-miss SIDS events. Many experts do not accept the association between ALTEs and SIDS. The lack of association between ALTEs and SIDS is supported by the following facts: (1) the incidence of SIDS has decreased since the 1994 "Back to Sleep Campaign", whereas the incidence of ALTEs has not; (2) half of ALTEs occur during wakefulness, whereas SIDS occurs mainly during sleep; (3) apnea and bradycardia events in ALTEs are less common during the early morning hours, when SIDS tends to occur; (4) apnea and bradycardia events are more common in Asians who are at lower risk for SIDS; (5) the age of mothers whose infants die of SIDS is younger compared with the age of mothers whose infants experience an ALTE; (6) incidence of ALTEs is equally distributed between boys and girls, whereas SIDS occurs more frequently in boys4 5).

Epidemiology

ALTEs occur predominantly in infancy at a mean age of 1–3 months4), and equally between boys and girls5). The incidence of ALTE was reported as 0.6–2.46 per 1,000 live births, 0.6%–1.7% of all ED visits for infants younger than 1 year of age, and 0.5%–6% of all infant visits5 6 7 8 9). The actual prevalence of ALTE may be higher than these figures. ALTE is associated with a 0%–7.6% mortality rate2 5).

Clinical presentation

ALTE is a diagnostic term based on clinical presentation. However, infants who experience an ALTE are often asymptomatic upon arrival at the hospital. Therefore, the first important step is to determine whether the individual symptoms qualify as ALTE criteria. In regards to the symptoms of apnea, shallow breathing, short episodes of central apnea lasting less than 30 seconds, and periodic breathing of the newborn could be normal events, if they are not associated with cardiac instability. Cyanosis, flushing, or acrocyanosis could also be reflective of normal changes in perfusion5).

Some infants with an ALTE often appeared healthy when they arrived at the ED or outpatient department, while other infants required immediate cardio-pulmonary resuscitation. This heterogeneity of ALTE presentation makes it difficult for clinicians to decide on how to assess and manage infants with an ALTE.

Evaluation

1. History

It is essential that a very thorough and detailed history is provided by a witness. We can assess the severity of the event and the underlying diagnosis by reviewing the patient's history. Caregivers may overestimate or underestimate the events because of their anxiousness after frightening events. The collected information should contain the following facts in Table 1 10 11).

Table 1

Historical information to obtain after apparent life-threatening events

2. Physical examination

Infants may have no signs or symptoms of significant illness after an ALTE. When infants with ALTE underwent physical examination by paramedics in the prehospital setting, 83% of the inants had no abnormal findings, 13.3% showed mild distress, and 3.3% showed moderate distress12). Infants who had abnormal findings during the initial clinical examination after an ALTE were more likely to have either recurrent ALTE or a definitive diagnosis7).

A physical examination should include the review of general appearance, vital signs, weight, height, and head circumference measurements. We need to be observant for neurological, respiratory, or cardiac abnormalities during the examination.

3. Further evaluation

Further evaluation of the patient with an ALTE is determined on the basis of their initial history and physical examination. There is no standard workup protocol, and the clinician should decide on the appropriate investigations depending on the circumstances of each individual case. The diagnostic procedures for ALTE infants are summarized in Table 2 10 11), and it is only a guideline for clinicians to refer to.

Table 2

Diagnostic evaluation of apparent life-threatening events

Tieder et al.13) demonstrated that tests for gastroesophageal reflux (GER), neurologic/hematologic/metabolic abnormalities, infections, ingestions of toxic materials, and cardiac dysrhythmias were the most frequently performed. In 2009, the Dutch Pediatric Association offered the first evidence-based consensus pathway for the diagnosis, management, and follow-up of children with an ALTE14). They recommend initial diagnostic tests for ALTEs that include the following: complete blood cell count with differential count, C-reactive protein, serum glucose, arterial blood gas analysis, urine analysis, electrocardiography, and assessments for seasonal virus such as Bordetella pertussis and respiratory syncytial virus (RSV). These tests are relatively inexpensive, sensitive, specific, and easy to perform. However, there is large inter-hospital diversity for the care of ALTE, including the costs of care.

Underlying etiology

There are several potentially dangerous or treatable conditions associated with ALTEs. The causes of ALTEs are divided into problems that are: gastrointestinal (GI) (50%), neurological (30%), respiratory (20%), cardiovascular (5%), metabolic and endocrine (2%–5%), and others such as child abuse (Table 3)10 11 15).

Table 3

Diagnosis of apparent life-threatening events

1. Digestive problems

The most common diagnosis is GI disease, including GER. However, an important consideration is that half of all normal infants aged 0–3 months may have daily regurgitation, so caution should be exercised before concluding GER to be a final diagnosis of an ALTE5 16). Upper GI series is neither sensitive nor specific17). The gold standard used in the diagnosis of GER is the 24-hour esophageal pH test, because it can demonstrate an association between GER and ALTEs. In addition, the intraluminal impedance helps to identify nonacid gastric reflux. However, these tests for GER are uncomfortable for infants and relatively expensive. Therefore, routine GER testing is not recommended for all infants with an ALTE18). GER tests should be considered for infants with: a history of frequent GER, an ALTE that occurs during or immediately after feeding, or gastric contents in their mouth of nose during an ALTE10).

2. Neurologic problems

Seizure is the most common neurologic disorder associated with ALTEs. Although electroencephalography (EEG) is first choice investigation for seizure, the sensitivity of EEG for diagnosing epilepsy is only 15%. Only 3.6% of infants with an ALTE were diagnosed with chronic epilepsy and in 71% of ALTE cases, a recurrent ALTE occurred within 1 month19). Thus, the use of EEG is considered for the evaluation of infants with recurrent ALTEs15). If EEG recordings are nondiagnostic, repeated EEGs or analysis of clinical history is important for diagnosing seizure20). Neurologic imaging, including cranial computed tomography (CT), magnetic resonance imaging, diffusion weighted imaging, and ultrasonography can help to diagnose chronic epilepsy, but it has a low sensitivity4).

One of notable cause of an ALTE is breath-holding spells, which typically have an emotional precipitant and usually occur while awake, and crying21). A rare cause of ALTEs is congenital central hypoventilation syndrome which usually occurs during sleep.

3. Respiratory problems

Obstructive sleep apnea, in association with anatomical abnormalities, infections, allergies or medications can induce ALTEs. Obstructive sleep apnea frequently occurs in premature babies, and obstructions are usually developed at the laryngeal level22). One of the common respiratory causes of ALTEs is infection, especially bronchiolitis caused by RSV23). An recent study showed that the age-group at high risk for apnea is: <1 month for full-term babies, and <48 weeks after conception for preterm babies24). Pertussis has been also identified as a cause of ALTEs7).

4. Cardiovascular problems

Cardiovascular problems are divided into 2 categories; structural heart disease and structurally normal hearts with arrhythmia, myocarditis, or cardiomyopathy. Electrocardiography is the important initial test for infants with an ALTE, and 24-hour continuous Holter monitoring can provide additional information for arrhythmias, such as long QT syndrome or paroxysmal tachycardia25).

5. Metabolic and endocrine problems

ALTEs can be an initial presentation of metabolic disorders. Clinicians should suspect an inborn error of metabolism if a patient with an ALTE has: (1) an atypical age (>1 year), (2) a failure to thrive, developmental delay, or seizures, (3) a family history of ALTEs, seizure disorders or SIDS, (4) laboratory abnormalities such as hyperammonemia, hypoglycemia, metabolic acidosis, elevated liver enzymes, or abnormal hemostasispatient10 15). Various metabolic abnormalities have been reported, including anomalies of mitochondrial fatty acid oxidation (medium chain acyl-CoA dehydrogenase deficiency), urea cycle defects (arginase deficiency), organic acidemias, and galactosemias26 27). Serum chemistry tests, including tests for sodium, potassium, urea, calcium, magnesium, ammonia, lactate, and pyruvate are inexpensive and simple, or sole diagnostic tools in some cases. Hence, we recommend these tests for the initial evaluation of ALTE.

Among the several infectious causes of ALTE, the prevalence were reported to be about 9%–82% for bronchiolitis, 0%–10% for lower respiratory tract infection, 0%–7.6% for urinary tract infection, 0%–2.5% for bacteremia, and 0%–1.6% for meningitis28 29 30 31).

6. Other conditions

One of most difficult and challenging diagnoses in infants with an ALTE is nonaccidental trauma. Although only less than 3% of ALTEs are related to child abuse21), the mortality associated with child abuse is high32). A clinician should keep in view the possibility of child abuse such as shaken baby syndrome and Munchausen by proxy. Several factors that may suggest abuse are recurrent ALTEs: previous occurrences of SIDS, fresh blood in the nose or mouth, delay in seeking medical care, a confusing or changing history, and the need for vigorous resuscitation during events33). A funduscopic examination should be included in the initial examination for retinal hemorrhage, and covert video surveillance can be used in suspicious cases34 35). Neurologic imaging, such as head CT can be used to identify head trauma, and should be considered for suspicious cases of abuse, to avoid unnecessary irradiation34).

7. Idiopathic ALTE

A diagnosable cause cannot be found in 35%–50% of total ALTE cases, despite the availability of a medical history and complete evaluation5 10 36). These cases are reported as idiopathic or unexplained ALTE.

Management

1. Criteria of admission

One study found that 13.6% of ALTEs had a subsequent extreme event, 85% of which occurred within the first 24 hours of hospitalization37). In another prospective study, 12% of infants had recurrent episodes within 24 hours in hospital, 9% required moderate stimulation, and 3% required resuscitation38). In a Korean study, Choi and Kim39) found that repeated ALTEs occurred in 69% of in-hospital infants that have experienced an ALTE. Therefore, regardless of the cause of the ALTE, all infants with an ALTE should require hospitalization, continuous cardiorespiratory monitoring and evaluation within at least 24 hours. The admission rate for ALTEs is usually 75%–100%33 36 37 40), which follows the recommendations of many centers. However, in some countries, the hospital charges cannot be ignored. Mittal et al.36) proposed a clinical decision rule and identified the risk factors for hospitalization: prematurity, cyanosis, abnormal findings at initial examination, and the absence of a history of choking and upper respiratory infection (URI) symptoms. Also, other studies suggested that the major indicators of admission and further evaluation were prematurity, an age <30 days or >60 days, history of combined underlying illnesses, multiple ALTEs occurring within 24 hours, and an abnormal result in the initial examination7 33 40). In Korea, the economic burden of admission is relatively low, so we strongly recommend that all infants with an ALTE should be admitted within 24 hours.

2. Treatment for individual causes

Appropriate medical or surgical treatment should be conducted for a specific cause of an ALTE. If GER is diagnosed as cause of an ALTE, interventions for GER such as feeding management, antireflux drugs, and surgical intervention may resolve further events11).

3. Education of caregivers

It is also important to educate the families. All caregivers of infants with an ALTE should be informed about preventative and emergency management (such as standard cardiopulmonary resuscitation techniques) for further episodes10). For prevention of an ALTE, safe sleep position (including the supine position, with the face free, in an adequately heated room) and avoiding exposure to tobacco smoke will be beneficial41).

4. Home monitoring

Cardiorespiratory monitors are the preferred devices for apnea monitoring. Although the effect of oxygen saturation monitoring alone is controversial, oxygen monitors have been used as an alternative to cardiorespiratory monitoring42 43 44). Home cardiorespiratory monitors help to alert caregivers to apnea and bradycardia. However, there is no evidence that apnea monitoring can prevent SIDS after an ALTE. Routine monitoring of all infants with an ALTE is not generally recommended. Although there are no accepted criteria to determine which patient should be home monitored, some publications recommended home monitoring for infants with an idiopathic ALTE or those who needed vigorous resuscitation42 45). Moreover, monitoring may be considered for infants with airway abnormalities (upper airway malformation or tracheostomy), idiopathic dysfunction of their respiratory center (CCHS), and chronic lung disease requiring oxygen supplementation and mechanical airway support42 46).

During home monitoring, continuous medical, psychological, and technical support will be needed for infants with ALTE and their caregivers. Home monitoring is usually stopped after a 6-week event-free period. For a preterm infant, usually it may be discontinued after 46 weeks' postmenstrual age42 46).

5. Follow-up

Recurrent ALTEs tend to occur during the first month after discharge46 47). Kant et al.48) reported that the mortality rate after discharge was 1.1% (2 deaths/174 infants) during 34 months of follow-up, and 2 cases of death occurred within 15 days of discharge. The other study of ALTE recurrence showed that 71% of the infants with an initial ALTE revisited the hospital with a second event within 1 month. Therefore, infants with an ALTE should be followed up at least within a month after discharge.

Prognosis and risk factors (for significant disease)

Recently, the natural course and prognosis of ALTEs has been more benign42), and the outcome usually depends on the associated underlying disease49). For infants with an idiopathic ALTE, the outcome is unpredictable10). In previous studies of ALTE prognosis after discharge, the mortality rate was reported to be 0%–1.1% during 12–60 months of follow-up6 19 33 48 50). However, Oren et al.51) reported that the risk of death was over 25% for infants in high-risk groups of ALTE, such as in cases where: (1) the events occurred during sleep, (2) resuscitation was needed, (3) there were recurrent episodes, (4) the infants were siblings of SIDS infants, and (5) the patient had a seizure disorder.

Many studies have investigated potential predictors of subsequent adverse events in infants with an ALTE, and they are similar to those for the indication that the patient was admitted to hospital. The most commonly mentioned risk factors are a history of prematurity and multiple ALTEs33 37 40). Some reports showed that infants with an age <30 days or infants that were born <43 weeks after conception were more likely to experience subsequent events37 40). In contrast, other studies found that an age >2 months was a factor that was associated with higher risk of recurrent ALTEs7 33). In regards to URI symptoms, one study reported an increased risk of subsequent ALTEs in infants that have URI symptoms37), whereas another study reported that there were more cases of investigation for ALTEs in infants with no URI symptoms, compared with the infants with URI symptoms36). In a Korean study conducted by Choi and Kim39), it was found that the infants with ALTEs that occurred during wakefulness and with URI symptoms had a higher risk of significant intervention.

Most infants with an idiopathic ALTE showed normal development during preadolescence52). However, some reports found that 4.9%–7.1% 4 of infants with ALTE developed adverse neurological outcomes, including chronic epilepsy and developmental delays19 53). In a Korean study, 15.4% of the infants showed developmental abnormalities during the 6-month follow-up period39). Inpatient neurologic evaluation of infants with a first ALTE has low sensitivity for adverse neurologic outcomes, and perinatal characteristics, birth status, recurrent apnea, and family history of seizures may be correlated with growth and developmental outcomes19 54). Long-term follow-up may be decided on an individual-case basis according to the underlying status of the infants.

Conclusions

Considering that ALTEs include a wide range of clinical presentations, ALTEs are an ongoing diagnostic dilemma for clinicians. A thorough, detailed history, and physical examination are the most important aspects of patient evaluation, and the clinician should decide appropriate further investigations on an individual-case basis. We recommend that all infants with an ALTE undergo inpatient clinical observation and evaluation, with at least 24 hours of cardiorespiratory monitoring. In addition, infants with an ALTE should be followed up at least within a month after discharge. The use of home monitoring and long-term follow-up activities should be decided on an individual basis according to the underlying status of the infants.

Notes

Conflicts of interest: No potential conflict of interest relevant to this article was reported.

References

1. American Academy of Pediatrics. Task Force on Prolonged Infantile Apnea. Prolonged infantile apnea: 1985. Pediatrics 1985;76:129–131. 4011346.

2. National Institutes of Health Consensus Development Conference on Infantile Apnea and Home Monitoring, Sept 29 to Oct 1, 1986. Pediatrics 1987;79:292–299. 3808807.

3. Willinger M, James LS, Catz C. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr Pathol 1991;11:677–684. 1745639.

4. Sahewalla R, Gupta D, Kamat D. Apparent Life-Threatening Events: An Overview. Clin Pediatr (Phila) 2016;55:5–9. 26092586.

5. Fu LY, Moon RY. Apparent life-threatening events: an update. Pediatr Rev 2012;33:361–368. 22855928.

6. Gray C, Davies F, Molyneux E. Apparent life-threatening events presenting to a pediatric emergency department. Pediatr Emerg Care 1999;15:195–199. 10389958.

7. Davies F, Gupta R. Apparent life threatening events in infants presenting to an emergency department. Emerg Med J 2002;19:11–16. 11777863.

8. Brooks JG. Apparent life-threatening events and apnea of infancy. Clin Perinatol 1992;19:809–838. 1464192.

9. Kiechl-Kohlendorfer U, Hof D, Peglow UP, Traweger-Ravanelli B, Kiechl S. Epidemiology of apparent life threatening events. Arch Dis Child 2005;90:297–300. 15723922.

10. Kahn A. European Society for the Study and Prevention of Infant Death. Recommended clinical evaluation of infants with an apparent life-threatening event. Consensus document of the European Society for the Study and Prevention of Infant Death, 2003. Eur J Pediatr 2004;163:108–115. 14652748.

11. Hall KL, Zalman B. Evaluation and management of apparent life-threatening events in children. Am Fam Physician 2005;71:2301–2308. 15999867.

12. Stratton SJ, Taves A, Lewis RJ, Clements H, Henderson D, McCollough M. Apparent life-threatening events in infants: high risk in the out-of-hospital environment. Ann Emerg Med 2004;43:711–717. 15159701.

13. Tieder JS, Altman RL, Bonkowsky JL, Brand DA, Claudius I, Cunningham DJ, et al. Management of apparent life-threatening events in infants: a systematic review. J Pediatr 2013;163:94–99.e1-6. 23415612.

14. Wijers MM, Semmekrot BA, de Beer HJ, Engelberts AC. Dutch Paediatric Association. Dutch Institute for Healthcare Improvement (CBO). Multidisciplinary guidelines for 'Apparent life threatening event' (ALTE). Ned Tijdschr Geneeskd 2009;153:A590. 20051156.

15. Shah S, Sharieff GQ. An update on the approach to apparent life-threatening events. Curr Opin Pediatr 2007;19:288–294. 17505188.

16. Arad-Cohen N, Cohen A, Tirosh E. The relationship between gastroesophageal reflux and apnea in infants. J Pediatr 2000;137:321–326. 10969254.

17. Tieder JS, Cowan CA, Garrison MM, Christakis DA. Variation in inpatient resource utilization and management of apparent life-threatening events. J Pediatr 2008;152:629–635. :635.e1–635.e2. 18410764.

18. Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49:498–547. 19745761.

19. Bonkowsky JL, Guenther E, Filloux FM, Srivastava R. Death, child abuse, and adverse neurological outcome of infants after an apparent life-threatening event. Pediatrics 2008;122:125–131. 18595995.

20. Anjos AM, Nunes ML. Prevalence of epilepsy and seizure disorders as causes of apparent life- threatening event (ALTE) in children admitted to a tertiary hospital. Arq Neuropsiquiatr 2009;67(3A):616–620. 19722037.

21. Kahn A, Rebuffat E, Franco P, N'Duwimana M, Blum D. Apparent life-threatening events and apnea of infancy. In : Berckerman RC, Brouillette RT, Hunt CE, eds. Respiratory control disorders in infants and children Baltimore: Williams and Wilkins; 1992. p. 178–189.

22. Ruggins NR, Milner AD. Site of upper airway obstruction in infants following an acute life-threatening event. Pediatrics 1993;91:595–601. 8441565.

23. Ricart S, Rovira N, Garcia-Garcia JJ, Pumarola T, Pons M, Muñoz-Almagro C, et al. Frequency of apnea and respiratory viruses in infants with bronchiolitis. Pediatr Infect Dis J 2014;33:988–990. 24797994.

24. Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med 2006;48:441–447. 16997681.

25. Woolf PK, Gewitz MH, Preminger T, Stewart J, Vexler D. Infants with apparent life threatening events. Cardiac rhythm and conduction. Clin Pediatr (Phila) 1989;28:517–520. 2805556.

26. Takahashi T, Yamada K, Kobayashi H, Hasegawa Y, Taketani T, Fukuda S, et al. Metabolic disease in 10 patients with sudden unexpected death in infancy or acute life-threatening events. Pediatr Int 2015;57:348–353. 25919294.

27. Arens R, Gozal D, Williams JC, Ward SL, Keens TG. Recurrent apparent life-threatening events during infancy: a manifestation of inborn errors of metabolism. J Pediatr 1993;123:415–418. 8355118.

28. Mittal MK, Shofer FS, Baren JM. Serious bacterial infections in infants who have experienced an apparent life-threatening event. Ann Emerg Med 2009;54:523–527. 19185390.

29. Brand DA, Altman RL, Purtill K, Edwards KS. Yield of diagnostic testing in infants who have had an apparent life-threatening event. Pediatrics 2005;115:885–893. 15805360.

30. Altman RL, Li KI, Brand DA. Infections and apparent life-threatening events. Clin Pediatr (Phila) 2008;47:372–378. 18057143.

31. Semmekrot BA, van Sleuwen BE, Engelberts AC, Joosten KF, Mulder JC, Liem KD, et al. Surveillance study of apparent life-threatening events (ALTE) in the Netherlands. Eur J Pediatr 2010;169:229–236. 19544071.

32. Crowcroft NS, Zambon M, Harrison TG, Mok Q, Heath P, Miller E. Respiratory syncytial virus infection in infants admitted to paediatric intensive care units in London, and in their families. Eur J Pediatr 2008;167:395–399. 17541638.

33. De Piero AD, Teach SJ, Chamberlain JM. ED evaluation of infants after an apparent life-threatening event. Am J Emerg Med 2004;22:83–86. 15011218.

34. Vellody K, Freeto JP, Gage SL, Collins N, Gershan WM. Clues that aid in the diagnosis of nonaccidental trauma presenting as an apparent life-threatening event. Clin Pediatr (Phila) 2008;47:912–918. 18648082.

35. Hall DE, Eubanks L, Meyyazhagan LS, Kenney RD, Johnson SC. Evaluation of covert video surveillance in the diagnosis of munchausen syndrome by proxy: lessons from 41 cases. Pediatrics 2000;105:1305–1312. 10835073.

36. Mittal MK, Sun G, Baren JM. A clinical decision rule to identify infants with apparent life-threatening event who can be safely discharged from the emergency department. Pediatr Emerg Care 2012;28:599–605. 22743742.

37. Al-Kindy HA, Gélinas JF, Hatzakis G, Cote A. Risk factors for extreme events in infants hospitalized for apparent life-threatening events. J Pediatr 2009;154:332–337. :337.e1–337.e2. 18950797.

38. Santiago-Burruchaga M, Sanchez-Etxaniz J, Benito-Fernández J, Vazquez-Cordero C, Mintegi-Raso S, Labayru-Echeverría M, et al. Assessment and management of infants with apparent life-threatening events in the paediatric emergency department. Eur J Emerg Med 2008;15:203–208. 19078815.

39. Choi HJ, Kim YH. Relationship between the clinical characteristics and intervention scores of infants with apparent life-threatening events. J Korean Med Sci 2015;30:763–769. 26028930.

40. Claudius I, Keens T. Do all infants with apparent life-threatening events need to be admitted? Pediatrics 2007;119:679–683. 17403838.

41. Kahn A, Bauche P, Groswasser J, Dramaix M, Scaillet S. Working Group, Groupe Belge de Pediatres Francophones. Maternal education and risk factors for sudden death in infants. Working Group of the Groupe Belge de Pédiatres Francophones. Eur J Pediatr 2001;160:505–508. 11548190.

42. Committee on Fetus and Newborn. American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003;111(4 Pt 1):914–917. 12671135.

43. Samuels MP, Southall DP. Alarms during apparent life-threatening events. Am J Respir Crit Care Med 2003;167:A677.

44. Côté A. Home and hospital monitoring for ALTE. Paediatr Respir Rev 2006;7(Suppl 1):S199–S201. 16798563.

45. Carroll JL. Apparent Life Threatening Event (ALTE) assessment. Pediatr Pulmonol Suppl 2004;26:108–109. 15029617.

46. Ramanathan R, Corwin MJ, Hunt CE, Lister G, Tinsley LR, Baird T, et al. Cardiorespiratory events recorded on home monitors: Comparison of healthy infants with those at increased risk for SIDS. JAMA 2001;285:2199–2207. 11325321.

47. Côté A, Hum C, Brouillette RT, Themens M. Frequency and timing of recurrent events in infants using home cardiorespiratory monitors. J Pediatr 1998;132:783–789. 9602186.

48. Kant S, Fisher JD, Nelson DG, Khan S. Mortality after discharge in clinically stable infants admitted with a first-time apparent life-threatening event. Am J Emerg Med 2013;31:730–733. 23399327.

49. Nunes ML, Costa JC, Ferreira CP, Garcia CC, Marques FC, Spolidoro JV. Associated and prognosis in apparent life threatening events (ALTE). J Pediatr (Rio J) 1999;75:55–58. 14685565.

50. Parker K, Pitetti R. Mortality and child abuse in children presenting with apparent life-threatening events. Pediatr Emerg Care 2011;27:591–595. 21712749.

51. Oren J, Kelly D, Shannon DC. Identification of a high-risk group for sudden infant death syndrome among infants who were resuscitated for sleep apnea. Pediatrics 1986;77:495–499. 3960618.

52. Kahn A, Sottiaux M, Appelboom-Fondu J, Blum D, Rebuffat E, Levitt J. Long-term development of children monitored as infants for an apparent life-threatening event during sleep: a 10-year follow-up study. Pediatrics 1989;83:668–673. 2717282.

53. Milioti S, Einspieler C. The long-term outcome of infantile apparent life-threatening event (ALTE): a follow-up study until midpuberty. Neuropediatrics 2005;36:1–5. 15776316.

54. Baroni MA. Apparent life-threatening events during infancy: a follow-up study of subsequent growth and development. J Dev Behav Pediatr 1991;12:154–161. 1869620.

Article information Continued

(open-access, http://creativecommons.org/licenses/by-nc/4.0/) :

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Description of event
Condition of child	Awake or asleep, position of infant (prone versus supine or on side), location of child (crib, parent’s bed, baby seat, other), bedclothes, blankets, pillows
Activity at the event	Feeding, coughing, gagging, choking, vomiting
Breathing efforts	None, shallow, gasping, increased
Color	Pallor, red, purple, blue, peripheral, whole body, circumoral
Movement and tone	Rigid, tonic-clonic, decreased, floppy
Cough, vomiting	Mucus, blood, or noise (silent, cough, gag, wheeze, stridor, crying)
Duration of the event	Length of time required to reinstate regular breathing and normal behavior or tone or length of time of resuscitation
Witness	Who discovered the ALTE and the reason that led to the discovery
Interventions	None, gentle stimulation, vigorous stimulation, mouth-to-mouth breathing, cardiopulmonary resuscitation by medically trained person
Present illness	Ill in days or hours leading up to event, fever, poor feeding, weight loss, rash, irritability, lethargy, contact with someone who is sick, medications administered, immunization
Medical history
Prenatal history	Use of drugs, tobacco, or alcohol during pregnancy
Birth history	Small for gestational age, prematurity, birth trauma, hypoxia, presumed sepsis
Feeding history	Breast or bottle-fed, gagging, coughing, poor weight gain
Development	Appropriate milestones
Previous admissions	Surgery, ALTE
Accidents	Being dropped or tossed; possibility of trauma
Family history	Congenital problems, neurologic conditions, neonatal and child deaths, smoking in the home, cardiac arrhythmia, siblings with and ALTE or SIDS

Evaluation	Potential diagnosis
Standard procedures
Complete child and family history
Medical examination of the infant
Complete blood count, pH, inflammatory tests	Infection, anemia, asphyxia
Blood electrolytes, urea, calcium, phosphate	Dehydration, hypo-/hyper-calcaemia
Blood glucose	Hypoglycaemia
Virology and bacterial screening	Infection
Nasopharyngeal aspirate	Upper airway infections
Urinalysis and culture, liver enzymes	Infection, metabolic screening
Chest X-ray film	Infection, cardiomegaly
Electrocardiogram	Arrhythmias, QTc anomaly
Stool culture	Infection
Ocular examination	Abuse, shaken infant
Specific procedures
Spinal fluid examination	Infection, hemorrhage, metabolic study
Skull X-ray film	Fracture, hypertension
Electroencephalogram	Seizure
Brain CT scan or MRI	Mass (tumor, hematoma)
Esophageal pH monitoring	Gastro-esophageal reflux
Esophageal barium study (or CT scan)	Anatomical abnormalities
ENT study, laryngoscopy	Airway obstruction or abnormality
Echocardiography	Congenital malformation, cardiac function
Metabolic work-up	Congenital metabolic abnormality
Skeletal survey	Fractures, malformations
Toxicology	Intoxication, drug effects
Craniofacial study and X-ray film	Facial dysmorphism
Sleep polygraphic study	Cardiorespiratory, neurological or oxygenation abnormalities
Tilt or other autonomic tests	Excessive autonomic responses
Video surveillance	Abuse, Munchausen by Proxy